Can Real-World Evidence Be Used To Remove LPAD's Limited Population Designation?

 
• By Michael Cipriano
Antibiotic resistant bacteria closeup biofilm
The US FDA will hold a public meeting on the LPAD draft guidance on 12 July.

More from Product Reviews

More from Pink Sheet